Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Accumulated Expenses (2020 - 2025)

Core Scientific (CORZW) has disclosed Accumulated Expenses for 6 consecutive years, with $512.0 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 691.65% to $512.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $512.0 million through Dec 2025, up 691.65% year-over-year, with the annual reading at $512.0 million for FY2025, 691.65% up from the prior year.
  • Accumulated Expenses hit $512.0 million in Q4 2025 for Core Scientific, up from $358.3 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $512.0 million in Q4 2025 to a low of $692220.0 in Q1 2021.
  • Historically, Accumulated Expenses has averaged $102.7 million across 5 years, with a median of $66.3 million in 2021.
  • Biggest five-year swings in Accumulated Expenses: soared 16965400.0% in 2021 and later crashed 73.55% in 2022.
  • Year by year, Accumulated Expenses stood at $67.9 million in 2021, then plummeted by 73.55% to $18.0 million in 2022, then surged by 900.65% to $179.6 million in 2023, then crashed by 64.0% to $64.7 million in 2024, then surged by 691.65% to $512.0 million in 2025.
  • Business Quant data shows Accumulated Expenses for CORZW at $512.0 million in Q4 2025, $358.3 million in Q3 2025, and $180.6 million in Q2 2025.